# Johnson & Johnson (JNJ) — Q2-2021 Earnings Results

**Report date:** 2021-07-21 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2021

## Post-Earnings Brief

### Headline

Johnson & Johnson Beats on EPS, Stock Up 0.62%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.48 | N/A | +8.77% |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the EPS results, highlighting ongoing efforts in innovation. However, they did not provide specific guidance for future quarters.

**Key quotes:**

> We are pleased with our performance this quarter.

> Our focus remains on innovation and meeting customer needs.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

The earnings report shows that Johnson & Johnson exceeded expectations on EPS, which likely contributed to the slight increase in stock price. The management's positive tone suggests confidence in their ongoing strategies, even without specific guidance for the future. Investors may view this as a sign of stability amid uncertainty in the market.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q2-2021_